Therapeutic Peptides intermediate
Goserelin Implant Technology
Biodegradable Zoladex implant technology providing sustained GnRH agonist release for hormone-dependent conditions.
By Encyclopeptide Editorial | 1 min read
goserelin implant Zoladex biodegradable GnRH
Chemical Identity
| Property | Value |
|---|---|
| Product Name | Zoladex |
| Active Component | Goserelin acetate |
| Dose | 3.6 mg (monthly) or 10.8 mg (3-monthly) |
| Route | Subcutaneous implant |
Implant Design
Biodegradable rod-shaped PLGA implant that slowly erodes over 28 days (3.6 mg) or 12 weeks (10.8 mg), releasing goserelin at a controlled rate.
Clinical Applications
- Prostate cancer (advanced, locally advanced)
- Breast cancer (premenopausal, ER-positive)
- Endometriosis
- Endometrial thinning (IVF protocols)
Biological Significance
This molecule plays important roles in biological systems and has potential therapeutic applications.
References
- Encyclopeptide Database. “Goserelin Implant Technology” monograph. encyclopeptide.com.
Test Your Knowledge
Reinforce what you learned about Goserelin Implant Technology with interactive quizzes on Wikipept.
Take a Quiz on Wikipept